Señales en vivo de MAAT.PA | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (3 may 2024 @ 10:40):

MaaT Pharma SA, a clinical stage company, engages in the research and development of microbiome biotherapies for the treatment of solid cancer tumors. Its products pipeline includes MaaT013 that has completed phase 2 clinical trials for the treatment of acute graft versus host diseases, as well as in preclinical trials to treat melanoma; MaaT033, which is in phase 1b clinical trials for the improvement of survival in patients with acute myeloid leukemia or other liquid tumors receiving allogeneic hematopoietic stem cell transplantation; and MaaT03X for the treatment of solid tumors...

Stats
Volumen de hoy	336.00
Volumen promedio	1 573.00
Capitalización de mercado	109.19M
EPS	€0 ( 2023-11-09 )
Last Dividend	€0 ( N/A )
Next Dividend	€0 ( N/A )
P/E	-5.53
ATR14	€0 (0.00%)

MaaT Pharma SA Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

MaaT Pharma SA Finanzas

Annual	2023
Ingresos:	€2.23M
Beneficio Bruto:	€784 000 (35.19 %)
EPS:	€-1.730

FY	2023
Ingresos:	€2.23M
Beneficio Bruto:	€784 000 (35.19 %)
EPS:	€-1.730

FY	2022
Ingresos:	€1.43M
Beneficio Bruto:	€1.09M (76.29 %)
EPS:	€-1.400

FY	2021
Ingresos:	€972 000
Beneficio Bruto:	€806 000 (82.92 %)
EPS:	€-0.948

Financial Reports:

No articles found.

MaaT Pharma SA